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ABSTRACT			
Within	the	diverse	interdisciplinary	life	sciences	domains,	semantic,	workflow,	and	methodological	
ambiguities	can	prevent	the	appreciation	of	explanations	of	phenomena,	handicap	the	use	of	
computational	models,	and	hamper	communication	among	scientists,	engineers,	and	the	public.		
Members	of	the	life	sciences	community	commonly,	and	too	often	loosely,	draw	on	“mechanistic	
model”	and	similar	phrases	when	referring	to	the	processes	of	discovering	and	establishing	causal	
explanations	of	biological	phenomena.		Ambiguities	in	modeling	and	simulation	terminology	and	
methods	diminish	clarity,	credibility,	and	the	perceived	significance	of	research	findings.		To	
encourage	improved	semantic	and	methodological	clarity,	we	describe	the	spectrum	of	Mechanism-
oriented	Models	being	used	to	develop	explanations	of	biological	phenomena.		We	cluster	them	into	
three	broad	groups.		We	then	expand	the	three	groups	into	a	total	of	seven	workflow-related	model	
types	having	clearly	distinguishable	features.		We	name	each	type	and	illustrate	with	diverse	
examples	drawn	from	the	literature.		These	model	types	are	intended	to	contribute	to	the	
foundation	of	an	ontology	of	mechanism-based	simulation	research	in	the	life	sciences.		We	show	
that	it	is	within	the	model-development	workflows	that	the	different	model	types	manifest	and	
exert	their	scientific	usefulness	by	enhancing	and	extending	different	forms	and	degrees	of	
explanation.		The	process	starts	with	knowledge	about	the	phenomenon	and	continues	with	
explanatory	and	mathematical	descriptions.		Those	descriptions	are	transformed	into	software	and	
used	to	perform	experimental	explorations	by	running	and	examining	simulation	output.		The	
credibility	of	inferences	is	thus	linked	to	having	easy	access	to	the	scientific	and	technical	
provenance	from	each	workflow	stage.		
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INTRODUCTION	
	The	use	of	“mechanistic	model”	and	similar	phrases	in	life	sciences	research	literature	continues	to	
increase	(Figure	1).		However,	there	is	considerable	diversity	in	what	is	being	implied	when	
discussing	mechanisms	and/or	describing	models	as	mechanistic.		Mechanistic	model	is	a	convenient	
yet	ambiguous	phrase	typically	used	as	an	abbreviation	for	more	accurate,	more	informative	
descriptors.		Use	of	the	term	“mechanism”	is	often	similarly	ambiguous.		In	any	scientific	community,	
clarity	within	research	reports	and	credibility	of	claims	made	are	generally	viewed	as	being	
correlated,	and	computational	biology	is	not	an	exception.		Usage	of	ambiguous	phrases	within	
simulation	research	reports	enhances	the	impression	of	inaccessibility,	which	can	limit	the	credibility	
and	acceptance	of	evidence	and	insights	being	presented	within	those	reports.		This	overview	is	
motivated	by	ongoing	collaborative	efforts	to	improve	credibility	and	the	belief	that	improvements	
in	semantic	and	methodological	clarity	will	strengthen	the	credibility	of	results	leveraging	simulation	
research.		
The	phrase	“mechanistic	model”	has	a	variety	of	meanings	ascribed	to	it	that	differ	across	biological	
domains.		There	is	an	increasing	tendency	to	utilize	“mechanistic	model”	both	specifically	and	as	an	
umbrella	term.		Herein,	we	define,	characterize,	and	cluster	seven	mechanistic	model	types,	and	
suggest	specific	terms	for	each.		To	insure	clarity,	we	narrow	the	scope	of	discussions	that	follow	by	
first	limiting	attention	to	reports	seeking	mechanism-oriented	explanations	of	biological	
phenomena.		We	further	restrict	focus	to	research	for	which	a	scientific	objective	is	to	1)	provide	
deeper,	more	explanatory	insight	into	the	generation	of	biological	phenomena;	and/or	2)	better	
predict,	mimic,	or	emulate	one	or	more	biological	phenomena.		
	
Figure	1:	Use	of	the	term	“Mechanistic”	in	literature		
There	is	a	rapid	increase	in	the	use	of	(A)	the	term	“mechanistic”;	and	(B)	derivative	phrases	(five	
shown)	in	biomedical	literature.		Results	are	from	a	PubMed	search	conducted	on	August	29,	2017.	
The	purpose	of	this	overview	is	to	illustrate	specific	ways	in	which	semantic	and	methodological	
clarity	regarding	mechanisms	and	explanations	of	phenomena	can	be	refined	to	improve	
accessibility,	and	ultimately,	credibility.		A	goal	is	to	clarify	various	uses	of	“mechanistic	model”	and	
how	they	are	represented	computationally	for	explaining	biological	phenomena.		We	describe	the	
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spectrum	of	Mechanism-oriented	Models	being	used	to	develop	explanations	of	biological	
phenomena.		We	cluster	explanations	of	phenomena	into	three	broad	groups	and	then	expand	them	
into	a	total	of	seven	model	types.		We	name	each	type	and	illustrate	with	diverse	examples	drawn	
from	the	literature.		We	begin	by	framing	the	context	and	offering	definitions.		In	“Methodological	
Complexity,”	we	contrast	how	infrastructure	and	management	of	complexity	influence	clarity	
differently	between	wet-lab	and	simulation	research.		In	the	section	that	follows,	we	describe	three	
spectra	that	are	useful	in	describing,	characterizing,	and	distinguishing	explanations	of	phenomena.		
Next,	in	“Three	Groups	of	Models	of	Explanation,”	we	use	similarities	and	differences		(with	
reference	to	the	spectra)	to	guide	characterizations	that	distinguish	semantically	among	seven	
workflow-centered	models	of	explanation,	including	four	different	types	of	computational	models	of	
explanation.		The	names	used	to	identify	each	characterization	are	not	intended	as	semantic	
standards;	rather	they	are	offered	as	suggestions	to	encourage	movement	in	that	direction	and	
serve	as	a	working	foundation	for	an	ontology	to	use	in	explanatory	simulation	research	in	the	life	
sciences.		In	“Relevant	Information,	Multiple	Sources,”	we	illustrate	why	providing	sufficient	
information	is	essential	to	enhance	credibility	of	an	explanatory	simulation,	whereas	brevity	
weakens	credibility	at	the	expense	of	clarity.		We	characterize	five	different	sources	and	types	of	
information	from	which	relevant	details	are	needed	to	clearly	distinguish	among	the	four	types	of	
computational	models	of	explanation.		In	“Workflow,	Provenance,	and	Hybrid	Models,”	we	comment	
on	connections	between	workflows	and	semantics,	and	on	new	technical	issues	that	further	increase	
the	need	for	semantic	clarity,	which	is	followed	by	“Concluding	Remarks.”		
BACKGROUND	
Framing	the	Context:	Mechanisms	as	Explanations	of	Phenomena	
A	prerequisite	for	discussing	mechanism-oriented	biological	models	is	adopting	a	definition	for	
“mechanism.”	Over	the	past	two	decades,	within	the	philosophy	of	science	literature,	mechanism	
has	emerged	as	a	framework	for	thinking	about	fundamental	issues	in	biology	[1,	2].	
Braillard	and	Malaterre	recently	defined	a	biological	mechanism	[3]:	
“A	mechanism	can	be	thought	of	as	being	composed	of	parts	that	interact	causally	(usually	
through	chemical	and	mechanical	interactions)	and	that	are	organized	in	a	specific	way.		This	
organization	determines	largely	the	behavior	of	the	mechanism	and	hence	the	phenomena	
that	it	produces.	…	Mechanisms	can	be	formalized	in	different	ways,	including	with	the	help	
of	diagrams	and	schemas,	and	are	usually	supplemented	by	causal	narratives	that	describe	
how	the	mechanisms	produce	the	very	phenomena	to	be	accounted	for.”	
Authors	often	augment	their	diagrams,	schemas,	and	causal	narratives	with	a	computational	
"narrative"	(algorithm	and	implementation)	that	enables	explicit	predictions.		We	use	the	definitions	
listed	in	Working	Definitions	Sidbar	and	specify	that	a	mechanism	is	a	real	thing;	it	is	concrete.		A	
description	is	required	for	the	term	“mechanistic	model.”		Kaplan	and	Craver	state	[4]:	
“[That]	the	line	that	demarcates	[mechanistic]	explanations	from	merely	empirically	adequate	
models	seems	to	correspond	to	whether	the	model	describes	the	relevant	causal	structures	that	
produce,	underlie,	or	maintain	the	explanandum	phenomenon.	This	demarcation	line	is	especially	
significant	as	it	also	corresponds	to	whether	the	model	in	question	reveals	(however	dimly)	knobs	
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and	levers	that	potentially	afford	control	over	whether	and	precisely	how	the	phenomenon	
manifests.”	
Thus,	we	see	that	there	is	a	difference	between	a	model	that	reproduces	a	phenomenon	and	a	model	
that	does	so	using	a	mechanism	that	recapitulates	the	‘true’	underlying	mechanism.			
(Sidebar)	Working	Definitions:	
mechanism	n	:	1)	a	structure,	system	(e.g.,	biological,	mechanical,	chemical,	electrical,	and	so	on),	or	
process	performing	a	function	in	virtue	of	its	component	parts,	component	operations,	and	their	
organization	(adapted	from	[5]),	where	the	function	is	responsible	for	the	phenomenon	to	be	
explained;	2)	entities	and	activities	organized	in	such	a	way	that	they	are	responsible	for	the	
phenomenon	to	be	explained	(adapted	from	[6,7])		
phenomenon	n	:	1)	an	observable	fact	or	event:	an	item	of	experience	or	reality;	2)	a	fact	or	event	of	
scientific	interest	susceptible	of	scientific	description	and	explanation	[8]		
mechanistic	adj	:	1)	determined	by,	for	example,	a	mechanical,	chemical,	and/or	electrical	
mechanism,	or	executing	software;	2)	like,	for	example,	a	mechanical,	chemical,	or	electrical	
mechanism	in	one	or	more	ways;	3)	of	or	relating	to	using	a	mechanism	as	an	approach	to	explaining	
a	biological	phenomenon;	4)	mechanism-oriented			
Craver	posits	that	mechanistic	models	are	explanatory,	but	he	notes	[9]:	
“Some	models	sketch	explanations	but	leave	crucial	details	unspecified	or	hidden	behind	
filler	terms.		Some	models	are	used	to	conjecture	a	how-possibly	explanation	without	regard	
to	whether	it	is	a	how-actually	explanation.”	
The	increasing	variety	and	sophistication	of	published	mechanism-oriented	and	mechanism-based	
explanatory	models	reflect	that	biological	mechanisms	exhibit	features	that	are	not	expressed	in	the	
Working	Definitions	Sidbar	definition	of	mechanism.		Darden	discusses	how	features	of	mechanisms	
often	become	necessary	parts	of	adequate	descriptions	and	representations	of	a	mechanism	[10].		She	
identifies	five	features	of	biological	mechanism,	listed	in	Table	1,	that	often	characterize	mechanisms	
that	adequately	explain	biological	phenomena.		These	features	will	be	useful	in	broadly	distinguishing	
among	model	types	and	may	provide	a	basis	for	further	developing	an	ontology	to	support	mechanism-
oriented	simulation	research.		The	phenomenon	to	be	explained	is	the	first	feature	because	the	search	
for	a	mechanism-based	model	of	explanation	requires	that	the	phenomenon	be	clearly	identified.		Also,	
in	biology,	it	is	often	the	case	that	phenomena	at	a	finer	biological	scale	constitute	the	explanatory	
mechanism	of	the	phenomenon	of	interest	observed	at	coarser	biological	scale.		Stated	differently,	the	
underlying	finer	details	are	the	entities	and	activities	responsible	for	observable	coarser	behavior.			
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Table	1	–	Five	features	of	a	biological	mechanism	(adapted	from	[10]):	a	biological	mechanism	
exhibits	all	five.		A	computational	mechanism-based	model	may	strive	to	do	the	same.		
Mechanism			
Features																		Examples													Explanations	
		
Phenomenon	
		 A	clearly	identified	phenomenon	is	the	requisite	for	specifying	the	
other	four	features	of	mechanism	and	for	developing	a	credible	
explanation	of	that	phenomenon.	
		
Components	
entities,	activities,	
modules,	processes,	
underlying	finer	
details	
Working	entities	act	in	the	mechanism.		Activities	are	producers	of	
change.		Some	entities	and	activities	can	be	organized	into	a	module.		
Inner	layer	phenomena	can	be	the	entities	and	activities	responsible	
for	the	outer	layer	phenomenon.	
Spatial	
arrangement	of	
components	
localization,	structure	
orientation,	
connectivity,	
compartmentalizatio
n	
Components	are	typically	localized	and	organized	into	a	structure.		A	
component’s	orientation	can	be	a	prerequisite	for	an	activity.		
Producing	change	requires	connectivity.		Compartmentalization	
facilitates	spatial	arrangement	within	a	structure.	
Temporal	
aspects	of	
components	
	
order,	rate,	duration,	
frequency	
Entities	may	play	their	role	is	a	particular	order.		Some	activities	have	
characteristic	rates.		Activities	can	occur	in	stages	and/or	exhibit	
temporal	organization.		An	activity	and/or	stage	can	repeat	or	exhibit	
frequencies.		Stages	can	unfold	in	a	particular	order	and	have	
duration.	
Contextual	
locations	
location	within	a	
hierarchy	and/or	
within	a	series	
A	mechanism	is	situated	in	wider	context,	such	as	within	a	hierarchy	
of	mechanism	levels	or	within	a	temporal	series	of	mechanisms	not	
directly	influencing	the	phenomenon	of	interest.		
METHODOLOGICAL	COMPLEXITY	
Methodological	complexity	has	been	increasing	in	wet-lab	research	for	decades.		However,	for	wet-
lab	researchers,	striving	for	clarity	in	descriptions	of	experiments	is	an	ingrained	best	practice,	
although	one	that	is	not	entirely	fulfilled	in	practice.		Ironically,	though	it	is	possible	to	fully	
document	every	aspect	of	software	used,	such	clarity	is	not	yet	the	norm	in	the	computational	
biology	research	domain.		Clarity	in	reports	of	wet-lab	methods	is	facilitated	and	enabled	by	a	large,	
trusted	commercial	infrastructure.		Research	reports	can	achieve	clarity	without	having	to	include	
pages	of	essential	yet	mind-numbing	details	by	including	statements	like	the	following	within	
Methods	sections,	e.g.,	from	[11]:	
“Dulbecco’s	phosphate	buffered	saline	(PBS),	liver	perfusion	medium,	hepatocyte	wash	medium	…	
were	purchased	from	Life	Technologies	(Carlsbad,	CA)	…	Wild-type	C57BL/6J,	male	mice	(9	weeks	
of	age),	purchased	from	The	Jackson	Laboratory	(Bar	Harbor,	ME),	were	acclimated	…	The	
resulting	supernatant	was	injected	into	the	high-performance	liquid	chromatography	column	
using	a	Model	582	solvent	delivery	system	and	a	Model	5600A	CoulArray	detector	(ESA,	
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Chelmsford,	MA)	…	Protein	content	was	determined	using	the	Nanodrop	2000	Spectrophotometer	
(Thermo	Scientific,	Waltham,	MA).”	
For	each	item,	additional	details	are	available	on	the	manufacturer	or	supplier’s	websites.		
Also,	many	portions	of	wet-lab	protocols	are	replicated	from	previous	publications	in	which	each	
step	was	explicated,	e.g.,	“cell	toxicity	was	measured	as	in	[hypothetical	reference].”		There	are	even	
entire	journals	devoted	to	the	distribution	of	standardized	and	generalizable	protocols,	e.g.,	“Journal	
of	Visualized	Experiments”	and	“Nature	Protocols.”		By	contrast,	in	biology	simulation	research,	
particular	computational	methods	are	often	borrowed	and	repurposed	but	are	rarely	implemented	
and/or	executed	identically.		Proprietary	and	open	source	simulation	tools	and	packages	are	
available,	but	we	do	not	yet	have	commercial	infrastructure	specifically	intended	to	facilitate	biology	
simulation	research.		
Growth	and	diversification	of	the	commercial	infrastructure	supporting	biology	research	have	
been	fueled	in	part	by	the	requirement	that,	when	needed,	experiments	can	be	independently	
reproduced	and	extended	in	a	different	laboratory.	That	requirement	also	drives	the	need	for	clarity	
in	wet-lab	methods.		Interest	in	independently	reproducing	results	of	simulation	experiments,	and	in	
reusing	and	repurposing	simulation	components	is	expected	to	increase	as	the	healthcare	
implications	and	benefits	of	simulation	experiments	increase.		Improved	clarity	at	all	workflow	
stages	will	facilitate	those	developments.		
MECHANISM-ORIENTED	MODELS	OF	EXPLANATION	
Based	on	our	sampling	of	the	research	literature,	all	explanations	of	phenomena	that	draw	on	
features	of	mechanisms	can	be	broadly	described	as	being	mechanism-oriented	models	of	
explanation.		They	differ	from	other	models	of	explanation	in	that	they	try	to	organize	knowledge	
about	both	phenomenon	and	its	explanation	around	mechanisms	[3].		The	explanations	are	models	
because,	even	when	there	is	considerable	knowledge	about	a	phenomenon,	there	is	still	uncertainty	
about	details	of	the	actual	causal	process,	and	those	details	always	exhibit	biological	variability.		
They	range	from	being	mechanism-oriented	to	fully	mechanism-based	models	of	explanation,	as	
illustrated	by	the	spectrum	in	Figure	2A,	and	can	be	grouped	under	one	of	three	broad	
characterizations.		I:	The	details	of	the	explanation	are	mechanism-oriented,	but	fall	short	of	the	
definition	in	the	Working	Definitions	Sidbar.		II:	The	explanation	is	mechanism-based	in	that	it	builds	
on	a	description	of	a	mechanism	that	meets	the	definition	of	mechanism	in	Working	Definitions	
Sidbar.		However,	the	mechanism	is	an	analogy	based	most	often	on	a	real	or	hypothetical	
engineering,	physical,	mechanical,	chemical,	and/or	electronic	mechanism.		III:	The	details	of	the	
mechanism-based	explanation	strive	to	be	biomimetic,	not	analogical:	some	entities	and	activities	
map	directly	to	biological	counterparts.		In	the	next	section,	we	explain	and	elaborate	these	three	
characterizations,	extend	them	to	include	four	types	of	computational	models	of	explanation	(IV-
VII),	and	present	examples	(the	seven	Roman	numerals	refer	to	the	names	of	model	types	
characterized	below	in	Group	A,	B,	and	C	subsections).		
II	and	III	have	two	requisites:	there	must	be	a	clear	mapping	between	the	representation	of	
entities	and	activities,	and	the	target	(referent)	phenomenon,	and	the	phenomenon	must	be	
specified	clearly.		Phenomena	are	grounded	to	the	particular	experiments	or	clinical	trials	in	which	
they	were	observed	and	measured.		In	research,	knowledge	of	a	phenomenon	can	vary	dramatically,	
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yet	there	is	a	direct	relationship	between	what	is	known	about	the	phenomenon	and	the	extent	to	
which	a	mechanism-oriented	model	of	explanation	can	become	sufficiently	accurate.		The	scope	and	
depth	of	knowledge	about	a	phenomenon	can	be	characterized	by	an	approximate	location	along	
the	spectrum	in	Figure	2B.		Phenomena	that	are	the	focus	of	more	basic	research	tend	to	have	
central	or	left-of-center	locations.		A	mechanism-oriented	or	mechanism-based	explanation	of	how	a	
phenomenon	is	thought	to	be—or	might	be—generated	can	be	characterized	by	an	approximate	
location	along	the	spectrum	in	Figure	2C.		Photosynthesis	provides	an	example	where	the	
explanation	of	the	phenomenon	is	located	right	of	center	on	the	Figure	2C	spectrum.		The	depth	of	
knowledge	is	such	that	explanatory	mechanisms	described	in	review	articles	and	textbooks	are	
broadly	accepted	as	accurate,	even	though	they	fall	far	short	of	a	full	and	complete	account	of	what	
actually	occurs	in	a	particular	plant	under	particular	conditions.		The	more	detailed	descriptions	
include	all	features	listed	in	Table	1.		As	such,	it	is	accurate	to	describe	such	an	explanation	as	a	
Model	Mechanism.			
	
Figure	2:	Three	spectra	for	characterizing	the	explanation	of	a	phenomenon	 	
(A)	This	spectrum	illustrates	relative	relationships	among	the	three	types	of	Mechanism-oriented	
Models	of	explanation	(I–III)	illustrated	and	named	in	Figure	3,	along	with	two	groups	of	
computational	models	of	explanation	illustrated	and	named	in	Figures	4	(IV–V)	and	5	(VI–VII).		There	
is	often	a	correlation	between	characterization	and	locations	on	this	spectrum	and	location	on	
spectra	B	and	C.		For	example,	having	locations	on	B	and	C	that	are	right	of	center	enables	an	
Analogous-mechanism	Model	to	be	more	biomimetic.		Explanations	that	use	mechanism	analogies	
often	have	more	centric	locations	on	B	and	C.		(B)	Specifying	an	approximate	location	on	this	
spectrum	provides	a	clear,	relativistic	assessment	about	the	strength	of	knowledge	and	information	
that	is	available	to	characterize	the	phenomenon.		Independent	of	location,	credibility	is	increased	
by	making	explicit	information	on	1)	how	the	phenomenon	has	been	measured,	along	with	2)	details	
about	temporal	measurements	of	entities	and	activities	thought	to	be	contributing	to	its	generation.		
Assessments	of	uncertainties	further	increase	credibility.		(C)	Specifying	an	approximate	location	on	
this	spectrum	characterizes	what	is	currently	known	or	hypothesized	about	how	the	phenomenon	in	
B	may	be	(or	is)	generated	along	with	information	about	the	mechanism	features	listed	in	Table	1	
and	their	orchestration.		Making	relative	spectra-location	information	explicit	is	essential	for	
increasing	credibility.				
Preprint:	Jan.	05,	2018	
	
8	
8	
Autoprotection	is	described	as	resistance	to	toxicant	re-exposure	following	acute,	mild	injury	
with	the	same	toxicant,	such	as	acetaminophen	[12,	13].		It	is	an	example	of	a	phenomenon	that	can	
be	characterized	as	located	on	the	far	left	of	the	spectrum	2B.			It	Knowledge	of	the	phenomenon	is	
sparse	and	imprecise.		Although	there	is	considerable	information	about	particular	molecular	details,	
only	incomplete	speculative	explanations	of	the	phenomenon	are	currently	feasible,	and	it	would	be	
difficult	to	distinguish	causes	from	effects.		Such	explanations	would	fall	short	of	the	definition	of	
mechanism,	and	so	would	be	located	considerably	left	of	center	on	the	spectrum	2C.		As	such,	weak	
Mechanistic	Explanation	is	an	accurate	descriptor,	and	any	possible	mechanism-based	account	
would	be	at	best	conjecture.		
THREE	GROUPS	OF	MODELS	OF	EXPLANATION	
A	huge	variety	of	explanatory	model	types	populates	the	Mechanism-oriented	Models	spectrum	in	
Figure	2A.		Having	characterizations	and	descriptors	that	make	it	easier	to	distinguish	among	classes	
and	types	is	essential	to	support	clarity	and	credibility,	aid	in	distinguishing	among	computational	
model	types,	and	provide	a	foundation	for	an	ontology.		We	identify	and	describe	seven	broad	types	
and	cluster	them	into	three	groups.		Group	A	includes	the	three	characterizations	illustrated	in	
Figure	3.		One	of	those	characterizations	is	a	requisite	core	component	of	each	of	the	four	
computational	Mechanism-oriented	Models	illustrated	in	Figure	4	(elaborations	of	I	and	II)	and	
Figure	5	(elaborations	of	III).		As	the	descriptors	and	names	for	different	models	of	explanation	gain	
traction,	attention	can	turn	to	discussions	of	finer	grain	model	types,	possibly	drawing	on	features	
listed	in	Table	1.	
Group	A:	three	types	of	Mechanism-oriented	Models	of	Explanation	
I:	Mechanistic	Explanation	
Mechanistic	explanations	are	pervasive	in	the	life	sciences	research	literature.		In	their	simplicity,	
they	are	analogous	to	a	cartoon;	they	are	static	and	reflect	observations.		Knowledge	about	the	
phenomenon	is	characterized	by	a	location	considerably	left	of	center	in	spectrum	2B	and	is	
insufficient	to	meet	the	definition	of	mechanism	in	the	Working	Definitions	Sidbar.		Nevertheless,	
there	is	often	sufficient	information	to	support	an	incipient	coarse	grain	causal	story	that	accounts	
reasonably	well	for	the	available	evidence	and	explains	how	the	phenomenon	might	have	been	
generated.		The	blue	box	in	Figure	3A	represents	the	workflow	required	to	identify	and	organize	
relevant	information	into	a	description	of	how	the	phenomenon	might	be	generated.		Such	
descriptions	typically	rely	heavily	on	explanatory	diagrams.		They	may	also	include	mathematical	
descriptions,	but	they	fall	short	of	the	definition	of	mechanism,	which	is	clear	in	the	three	examples	
that	follow.		It	is	understood,	but	often	not	stated,	that	many	somewhat	different,	yet	equally	
possible	explanatory	models	can	be	presented.		An	accurate	descriptor	is	a	Mechanism-oriented	
Model	of	Explanation.		However,	because	we	use	that	phrase	as	an	umbrella	expression,	we	prefer	
the	abridged	phrase,	Mechanistic	Explanation,	which	we	use	hereafter.				
Preprint:	Jan.	05,	2018	
	
9	
9	
	
Figure	3:	Three	types	of	Mechanism-oriented	Models	of	Explanation	
There	are	three	broad	types	of	Mechanism-oriented	Models	of	explanations	of	phenomena.		They	
overlap	to	some	extent.		These	illustrations	highlight	features	that	differentiate	the	three	types.		
Credibility	improves	by	making	clear	which	type	best	characterizes	a	specific	model	of	explanation.		
(A)	A	Mechanistic	Explanation	has	the	illustrated	features	and	is	located	left	of	center	in	Figure	2A.		
The	muted	oval	at	top,	which	is	repeated	in	Figures	4	and	5,	reminds	us	that	the	actual	causal	
explanation	is	yet	to	be	discovered.		The	hexagon	depicts	the	target	phenomenon.		Each	
phenomenon	can	be	characterized	by	its	relative	(to	other	phenomena)	location	on	the	Figure	2B	
spectrum.		The	hexagon	represents	the	organized	relevant	information	about	the	phenomenon	that	
is	being	explained.		The	process	(the	workflow)	of	identifying	and	organizing	information	and	
features	into	a	description	of	how	the	phenomenon	might	be	generated	is	represented	by	the	blue	
box.		Part	of	the	workflow	involves	establishing	mappings	and	drawing	analogies	between	features	
of	the	explanation	and	particular	measurements;	the	darker	gray	arrow	indicates	that	activity.		The	
lighter	gray	arrow	indicates	a	working	hypothesis,	in	which	those	mappings	and	analogies	will	
eventually	be	extend	to	the	actual	causal	explanation.		Those	three	differentia	are	part	of	the	model.		
(B)	This	model	type	includes	a	detailed	description	and	explanation	(blue	box)	along	with	the	other	
elements	in	A,	as	implied	by	the	incomplete	gray	arrow.		Information	about	possible	generators	(of	
the	target	phenomenon)	is	sufficient	to	conceptualize	and	describe	an	explanation	that	meets	the	
definition	of	mechanism	in	the	Working	Definitions	Sidbar	by	drawing	on	analogies	to,	for	example,	
engineering,	mechanical,	chemical,	or	electronic	mechanisms.		The	result	is	an	Analogous-
Mechanism	Model	of	explanation.		The	red	asterisks	designate	characteristics	that	distinguish	II	from	
I.		(C)	Further	right	on	both	the	2B	and	2C	spectra,	knowledge	about	the	phenomenon	is	sufficient	to	
conceptualize	a	model	of	explanation	that	includes	several	of	the	Table	1	explanatory	biomimetic	
features.		The	resulting	detailed	description	and	explanation	is	fundamentally	different	from	II:	it	is	a	
description	of	a	Model	Mechanism	explanation.		It	includes	a	more	detailed	description	and	
explanation	(blue	box)	along	with	the	other	elements	in	A,	which	is	implied	by	the	incomplete	gray	
arrow.		The	red	asterisks	designate	characteristics	that	distinguish	III	from	II.		
•	Example	I-1:		The	well-known	Hodgkin	and	Huxley	model	is	a	Mechanistic	Explanation.		It	is	an	
incomplete	how-possibly	story	that	provides	preliminary	insights	into	mechanisms	responsible	
for	generating	and	propagating	action	potentials	along	axons	[14].		The	authors	make	clear	that	
their	account	is	merely	an	explanatory	model,	not	an	actual	explanation.			
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“…certain	features	of	our	equations	were	capable	of	a	physical	interpretation,	but	the	success	
of	the	equations	is	no	evidence	in	favour	of	the	mechanism	of	permeability	change	that	we	
tentatively	had	in	mind	when	formulating	them.”	
•	Example	I-2:		Russmann	et	al.	[15]	offer	a	three-step	Mechanistic	Explanation	of	how	hepatocyte	
death	may	be	caused	during	drug	induced	liver	injury.		1)	The	initial	injury	results	in	direct	cell	
stress	possibly	including	mitochondrial	impairment.		2)	Death	receptor-mediated	pathways	are	
triggered	leading	to	mitochondrial	permeability	transition.		3)	The	result	is	apoptotic	or	necrotic	
cell	death.			
•	Example	I-3:		Bassler	et	al.	[16]	sought	Mechanistic	Explanations	for	unanticipated	clinical	side	
effects	and	efficacy	limitations	of	integrin	αIIbβ3	antagonists.		They	posited	a	three-stage	
Mechanistic	Explanation	involving	paradoxical	platelet	activation	by	αIIbβ3	antagonists:	a	ligand-
bound	conformation	change;	receptor	clustering;	and	pre-stimulation	of	platelets.			
II:	Analogous-Mechanism	Model	
It	is	common	to	encounter	a	mechanism-oriented	explanation	of	biological	phenomenon	that	is	
framed	as	a	mechanism	analogy	based	on	engineering	principles,	continuum	mechanics,	chemistry,	
electronics,	etc.		When	the	analogical	explanation	meets	the	definition	of	mechanism,	it	can	be	
accurately	identified	as	an	Analogous-Mechanism	Model	of	Explanation	(simply	Analogous-
Mechanism	Model	hereafter).		It	too	is	supported	by	diagrammatic	depictions	and	often	includes	
mathematical	descriptions.		Like	I,	it	is	still	cartoonish.		There	is	more	cause	and	effect	than	in	I.		
Although	the	mechanism’s	phenomenon	is	expected	to	be	biomimetic,	features	of	the	mechanism’s	
components,	their	spatial	arrangement,	and/or	temporal	aspects	are	typically	not	biomimetic.		The	
following	are	examples.			
•	Example	II-1:		The	three-element	Hill	muscle	model	for	estimation	of	muscle	force	generation	
[17]	is	an	idealized	Analogous-Mechanism	Model	(Figure	3B).		Such	models	do	not	have	direct	
biological	counterparts,	and	any	contextual	location	is	hypothetical.		However,	measurements	of	
the	idealized	mechanism	during	operation—if	it	were	made	real,	concrete—are	expected	to	
adequately	match	measurements	of	the	target	phenomenon	qualitatively	and	quantitatively.		
•	Example	II-2:		Some	therapeutic	proteins	such	as	trastuzumab,	which	is	a	monoclonal	antibody,	
bind	to	pharmacological	targets	on	cells.		Efficacy	is	disrupted	when	the	therapeutic	protein	
binds	instead	to	soluble	targets	shed	from	cells.		Li	et	al.	[18]	describe	a	minimal	physiologically	
based	pharmacokinetic	Analogous-mechanism	Model	intended	to	represent	key	features	of	a	
plausible	mechanism	hypothesized	to	be	responsible	for	reduced	efficacy.		A	computational	
description	of	their	model	in	operation	was	used	to	simulate	efficacy	changes.		
•	Example	II-3:		Demographic	collapse	of	freshwater	fish	species,	such	as	brown	trout,	can	occur	
when	rates	of	environmental	change	exceed	the	population’s	capacity	to	adapt.	Ayllón	et	al.	[19]	
describe	a	spatially	explicit,	multi-attribute,	eco-genetic	individual-based	Analogous-mechanism	
Model	that	was	used	to	study	possible	trout	dynamics	under	three	scenarios:	1)	climate	change-
induced	warming,	2)	warming	plus	flow	reduction	resulting	from	climate	and	land	use	change,	
and	3)	a	baseline	of	no	environmental	change.			
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A	phenomenon	that	is	explained	using	an	Analogous-mechanism	Model	will	be	to	the	right	of	
I	in	Figure	2B.		As	explanatory	insight	improves	and	the	research	workflow	advances,	one	encounters	
research	reports	in	which	an	earlier	Mechanistic	Explanation	is	replaced	by	an	Analogous-
mechanism	Model.		At	that	stage,	authors	typically	assign	names	to	some	or	all	of	the	components	
of	their	model	that	are	identical	to	real	components	and	features	of	the	referent	biological	system,	
i.e.,	they	draw	directly	from	vocabularies	of	anatomical	or	physiological	ontologies.		While	
conceptually	useful,	such	labeling	can	encourage	conflating	model	explanation	features	with	reality,	
which	reduces	both	clarity	and	scientific	credibility.		
III:	Model	Mechanism	
As	explanatory	knowledge	about	a	phenomenon	increases	(moving	further	right	on	the	Figure	2B	
spectrum),	researchers	begin	conceptualizing	and	describing	(hypothesizing	about)	a	particular	
mechanism-based	explanation	of	the	phenomenon	(Figure	3C)	that	is	biomimetic;	it	is	not	an	
analogy	of	something	else.		Researchers	strive	to	identify,	specify,	and	characterize	some	or	all	of	the	
explanatory	features	in	Table	1.		Model	Mechanism	is	an	accurate	descriptor	of	the	product	of	that	
process.		Model	Mechanisms	are	less	cartoonish	than	II	and	more	structured.		An	early	stage	model	
of	explanation	of	this	type	would	likely	be	assigned	a	central	location	on	spectrum	2A.		As	a	
description	matures,	its	location	on	all	three	Figure	2	spectra	shift	rightward.		Mappings	exist	
between	the	Model	Mechanism’s	discrete	entities	and	activities,	and	biological	counterparts.		The	
expectation	is	that	measurements	of	a	phenomenon	generated	during	simulation	of	an	actualized	
Model	Mechanism	would	adequately	match	measurements	of	the	actual	target	phenomenon	
qualitatively	and	quantitatively.			
•	Example	III-1:	An	illustrative	example	is	the	two-dimensional	model	mechanism	developed	by	
Norton	et	al.	[20]	to	facilitate	achieving	two	related	goals:	1)	improve	explanatory	insight	into	
the	generation	of	the	four	distinguishable	morphologies	of	ductal	carcinoma	in	situ	of	the	
breast.		2)	Disentangle	the	mechanisms	involved	in	tumor	progression.		Additional	examples	are	
included	with	those	provided	below	under	Group	C.	
Group	B:	using	simulation	to	support	and	enhance	I	and	II	
IV:	Simulation	of	a	Mechanistic	Explanation	
A	frequent	simulation	research	goal	is	to	translate	a	Mechanistic	Explanation	(I)	into	simulation	
output	that	is	(or	is	expected	to	be)	qualitatively	or	quantitatively	similar	to	reported	measurements	
of	the	target	phenomenon.		An	additional	goal	may	be	providing	predictions	and/or	further	
improving	insight	into	how	the	target	phenomenon	(and	possibly	other	phenomena)	may	be	
generated.		A	Simulation	of	a	Mechanistic	Explanation	(Figure	4A)	builds	upon	I	during	three	
workflow	activities.		1)	Relational	and	continuum	mathematical	descriptions	are	developed	of	the	
salient	explanatory	information	within	the	Mechanistic	Explanation.		2)	Those	descriptions	are	
instantiated	in	software;	features	to	facilitate	exploratory	simulations	are	added;	solvers	are	
selected,	and	the	implementation	undergoes	verification.		3)	An	iterative	workflow	process	achieves	
the	desired	qualitative	and	quantitative	similarity	between	simulation	output	and	measurements	of	
the	target	phenomenon.		During	that	process,	the	implemented	model	and	mathematical	
descriptions	may	be	revised.		To	enable	another	modeler	to	independently	reproduce	reported	
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simulation	results,	details	of	those	workflow	decisions	should	be	made	available	when	results	are	
published	[21].		For	the	second	and	third	activities,	it	is	increasingly	common	for	researchers	to	rely	
on	mathematical	modeling	tools,	such	as	Matlab	(The	MathWorks,	Inc.,	Natick,	MA),	and/or	
proprietary	or	open	source	systems,	including,	for	example,	physiologically	based	simulation	or	
emulation	packages	(e.g.,	see	[22]).		Use	of	standardized	software	increases	credibility,	reliability,	
and	reproducibility	by	providing	some	assurance	that	the	underlying	numerical	techniques	are	
handled	correctly.		Use	of	open	source	software	further	improves	reproducibility	by	making	the	
simulation	widely	available	while	also	opening	the	underlying	techniques	to	later	examination	for	
correctness.		
Technically,	the	simulation	output	is	a	model	of	solutions	to	the	relational	and	mathematical	
descriptions	under	particular	conditions;	and	the	mathematical	descriptions	are	a	model	of	the	
mechanistic	explanation	in	I	given	particular	assumptions	and	constraints.		Consequently,	when	
“mechanistic	model”	or	“mechanistic	simulation	model”	is	used	to	describe	the	work	product,	it	can	
be	difficult	for	a	reader	to	know	which	model	is	being	identified.		To	avoid	misinterpretations,	this	
type	of	work	product	can	be	identified	accurately	as	a	Simulation	of	a	Mechanistic	Explanation.		The	
following	are	two	related	examples.			
	
Figure	4:	Characterizations	of	two	types	of	simulation	
Illustrated	are	work	activities	built	upon	explanations	carried	forward	from	I	and	II.		Simulation	
operation	is	not	illustrated.		A	requirement	for	both	types	of	simulation	is	that	output	(specific	
computed	solutions)	match	target	phenomenon	measurements	within	some	tolerance.		(A)	Starting	
with	a	Mechanistic	Explanation	(I),	the	modeler	completes	two	tasks.	1)	Develop	relational	and	
continuum	mathematical	descriptions	of	the	mechanistic	explanation’s	salient	information.		2)	
Faithfully	instantiate	in	software	all	mathematical	descriptions	such	that	computed	solutions	
simulate	the	output	envisioned	by	a)	those	mathematical	descriptions	and	b)	the	mechanistic	
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explanation’s	salient	information.		The	resulting	software	system	provides	a	Simulation	of	a	
Mechanistic	Explanation.		Prior	to	publication,	the	system	has	typically	undergone	several	rounds	of	
refinement	and	revision.		(B)	Starting	with	II,	the	modeler	develops	the	mathematical	and	numerical	
mathematical	descriptions	needed	to	provide	faithful	characterizations	of	the	analogous	
mechanism’s	salient	features	during	operation.		The	requirements	for	software	instantiation	are	the	
same	as	for	A.		The	resulting	system	simulates	output	from	II,	as	if	it	were	real.		Red	asterisks:	
characteristics	that	distinguishes	B	from	A.		
•	Example	IV-1:	The	gamma	rhythm	is	one	of	several	characterized	oscillations	of	activity	in	the	
brain	(brain	waves).		The	alpha	rhythm	of	about	8	Hz	is	powerful	enough	that	it	can	be	readily	
detected	outside	of	the	head,	something	discovered	in	the	1920s	by	Hans	Berger.		In	contrast	to	
alpha,	gamma	oscillations	are	faster	(~40	Hz)	and	more	spatially	localized,	best	detected	by	
electrodes	placed	directly	on	the	brain	surface	or	into	the	brain	parenchyma.		A	Simulation	of	a	
Mechanistic	Explanation	[23]	helped	explore	how	these	gamma	oscillations	could	be	generated	
through	inhibitory	inputs,	which	were	classically	thought	of	as	delaying	or	eliminating	neural	
activity.		Wang	and	Buzsaki	demonstrated	a	mechanistic	explanation	wherein	inhibitory	inputs	
could	in	some	cases	paradoxically	facilitate	activity	[24].		The	dual	roles	of	inhibition	and	
facilitation	allow	it	to	entrain	cell	activity	to	a	signal	originating	in	inhibitory	cells.			
A	relatively	fine-grained,	multi-formalism	model	is	required	to	represent	an	entrainment	
mechanism	by	a	simulated	cell's	inputs,	at	one	scale,	and	the	synchronization	of	multiple	cells	to	
plausibly	generate	gamma	waves	at	a	network	scale.	These	simulations	comprised	local	systems	
of	ODEs,	combined	with	a	coarse	PDE	approximation	to	represent	the	single	neuron,	with	event-
driven	techniques	to	connect	cells	into	networks.		To	illustrate	where	this	example	fits	into	the	
spectrum	of	types	(Fig.	2A),	it	is	useful	to	focus	on	the	way	the	authors	modeled	ion	channels,	as	
systems	of	ODEs.		Two	cross-model	alternatives	were	used,	a	coarse	3-channel	and	a	fine	11-
channel	representation,	both	ultimately	derived	from	the	underlying	Hodgkin-Huxley	
framework.	Practically,	using	these	alternatives,	helped	allow	for	cross-model	validation	in	the	
face	of	the	greater	computational	complexity	of	the	11-channel	simulations.		However,	from	a	
model	of	explanation	perspective,	it	is	important	to	note	that	the	11-channel	parameterization	
maps	more	closely	to	ion	channel	biophysics.		So	while	both	alternatives	are	simulations	of	
mechanistic	models,	in	that	they	are	numerical	solutions	to	systems	of	ODEs,	the	finer	grained,	
11-channel	representation	is	further	to	the	right	on	the	Fig.	2A	spectrum,	toward	an	Analogous-
mechanism	Model	and,	ultimately,	a	Model	Mechanism.		Hence,	this	example	exhibits	different	
locations	along	the	spectrum	of	types.		It	also	demonstrates	use	of	methods	for	moving	back	and	
forth	along	that	spectrum.			
•	Example	IV-2:		More	recent	mechanistic	explorations	of	gamma	oscillations	have	focused	on	
their	possible	role	in	the	genesis	of	schizophrenia,	where	abnormalities	in	gamma	oscillations	
have	been	demonstrated.		Other	clues	to	the	biological	explanation	of	schizophrenia	have	come	
from	analogies	with	psychotomimetic	drugs,	such	as	ketamine.	More	recently,	possible	roles	of	
particular	molecular	abnormalities	have	been	suggested	by	a	genome-wide	association	study.		
These	many	scales	of	causality	were	assessed	by	Neymotin	et	al.	[25]	using	multiscale	
simulations	of	a	mechanistic	explanations	to	explore	how	alterations	in	one	of	the	neural	
receptors	at	molecular	scale	might	produce	alterations	in	gamma	oscillations	in	neuronal	
networks	at	the	tissue	scale.		By	using	both	dynamical	and	information	theoretic	measures,	
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simulation	suggested	how	anomalies	in	neuronal	activity	might	produce	disturbances	in	function	
--	disturbances	in	information	flow.	Thus	the	model	illustrates	several	levels	of	mechanistic	
explanation,	connecting	molecular	anomalies	with	cellular	anomalies,	network	anomalies	and	
information	transmission	disturbance.		Neurons	were	modeled	with	piecewise	integrated	
difference	equations,	including	inputs	on	the	soma	and	dendrites,	representing	transmitted	as	
well	as	background	molecules	and	their	receptors.		Networks	of	simulated	neurons	were	
composed	according	to	a	fixed	relationship	between	three	different	neuron	types.	Simulated	
current	injections	were	used	to	drive	the	network	to	a	baseline	activity,	and	then	tuned	to	
generate	baseline	theta,	gamma,	and	theta-modulated	gamma	oscillations	in	a	Local	Field	
Potential	(LFP)	spanning	the	simulated	pyramidal	neurons.		The	LFP	oscillations	provide	the	
distinguishing	phenomena.	The	simulated	intervention	mechanism	consisted	of	turning	on	and	
off	the	NMDA	(N-methyl-D-aspartate)	inputs	across	16	different	cellular	locations.		Because	the	
interventions	are	below	the	network	scale,	instantiated	by	the	underlying	software,	and	mapped	
to	the	derived	properties	of	the	LFP	oscillations,	this	model	provides	an	excellent	example	of	
Simulation	of	a	Mechanistic	Explanation.		Further,	each	neuron	is,	itself,	an	example	of	IV,	in	that	
it	is	a	collection	of	sections	(soma	and	dendrites),	each	of	which	is	a	system	of	difference	
equations	propagating	the	inputs.	However,	the	neuronal	network	is	designed	using	random	
connectivity,	since	there	are	no	data	on	actual	cell-to-cell	connectivity.		Therefore,	at	this	level,	
the	model	is	only	structurally	evocative	of	the	referent	and	thus	approaches	a	Simulation	of	an	
Analogous-mechanism	model	(V).		By	using	the	information	theoretic	measures	to	relate	the	
external	inputs	to	spike	outputs,	the	authors	were	able	to	demonstrate	an	inverse	relation	
between	gamma	activity	and	the	ability	of	the	network	to	transmit	information,	to	demonstrate	
how	gamma	oscillation	might	underlie	information	processing	and	how	gamma	oscillation	
anomalies	could	underlie	the	abnormal	information	processing	in	schizophrenia.			
V:	Simulation	of	an	Analogous-mechanism	Model	
When	starting	with	a	description	of	an	Analogous-mechanism	Model	(II),	the	simulation	research	
goal	is	often	to	translate	the	knowledge	contained	within	its	description	into	simulation	output	that	
is	qualitatively	and	quantitatively	similar	to	measurements	of	the	target	phenomenon.		When	
successful,	an	accurate	descriptor	of	the	work	product	is	Simulation	of	an	Analogous-mechanism	
Model.		An	increasing	fraction	of	computational	explanations	of	phenomena	reported	in	the	
literature,	including	some	“mechanistic	models”	described	as	being	“multiscale”	[26],	fit	reasonably	
well	under	that	descriptor	(e.g.,	see	[27-32]).			
Figure	4B	is	a	snapshot	of	the	process	of	building	upon	descriptions	in	II	during	workflow	
activities	that	differ	from	those	for	IV	in	important	ways.		1)	The	scientist	creates	mathematical	
descriptions	of	the	Analogous-mechanism	Model	in	operation.		Continuum	equations	are	adapted	
from	descriptions	of	engineering,	physical,	mechanical,	chemical,	and/or	electronic	mechanisms.		An	
important	subset	of	those	mathematical	descriptions,	e.g.,	finite	element	analysis,	goes	beyond	
continuum	mathematical	descriptions	because	they	also	require	numerical	analysis	techniques.		2)	
The	mathematics	is	instantiated	in	software;	features	to	support	users	are	added;	and	solvers	are	
selected.		Computational	solutions	involve	solving	equations	subject	to	boundary	conditions	and/or	
initial	conditions,	and	the	implementation	undergoes	verification.		3)	Authors	undertake	the	iterative	
process	of	achieving	qualitative	and	quantitative	similarity	between	simulation	output	and	
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measurements	of	the	target	phenomenon	within	some	tolerance.		The	product	of	that	process	is	
output	from	selected	parameterizations	of	a	Simulation	of	an	Analogous-mechanism	Model.		The	
following	are	examples.		
•	Example	V-1:		Based	on	epidemiological	studies,	high-density	lipoprotein	(HDL)	is	believed	to	
play	an	important	role	in	lowering	the	risk	of	cardiovascular	disease	by	mediating	reverse	
cholesterol	transport.		Therapies	that	raise	HDL-cholesterol,	however,	have	been	unable	to	
confirm	this	hypothesis	and	demand	a	re-examination	of	the	proposed	mechanism.		It	is	known	
that	lipid-poor	ApoA-I	plays	a	role	in	initiating	reverse	cholesterol	transport	and	that	the	drug	
RG7232	increases	HDL-cholesterol.		However,	the	influence	of	RG7232	on	lipid-poor	ApoA-I	and	
reverse	cholesterol	transport	is	unclear	because	their	direct	measurement	during	dosing	
intervals	is	problematic.		Lu	et	al.,	[28]	developed	an	Analogous-mechanism	Model	and	
corresponding	simulation	to	explore	this	response.		The	model	is	based	on	two	other	Analogous-
mechanism	Models,	1)	a	model	of	lipoprotein	metabolism	and	kinetics	and	2)	a	model	of	
RG7232	pharmacokinetics.		They	are	combined	into	a	single	simulation.	The	linked	simulation	
goes	further	by	additionally	representing	the	hypothesis	that	the	affinity	of	low-density	
lipoprotein	(LDL)	particles	to	LDL	receptors	is	dependent	on	particle	size	or	density.		This	
hypothesis	is	implemented	as	a	modified	elimination	rate.		The	resulting	model	describes	
temporal	concentrations	in	two-compartments	as	coupled	ordinary	differential	equations	that	
are	solved	using	the	SimBiology	toolbox	of	MathWorks.		The	simulation	model	is	"analogous"	in	
the	sense	that	the	proposed	density-dependent	elimination	rate	and	compartmentalization	is	an	
analogy	to	chemical	kinetics	and	chemical	engineering.		Parameters	are	estimated	using	a	
Bayesian	approach	that	updates	the	parameter	values	from	model	components	using	the	
Matlab	Global	Optimization	toolbox	of	MathWorks.		The	implementations	simulate	output	from	
the	linked	Analogous-mechanism	Model,	as	if	it	were	real.			
•	 Example	V-2:		More	than	40%	of	astronauts	who	participate	in	long-duration	missions	return	
with	ophthalmic	changes	similar	to	idiopathic	intracranial	hypertension.		Experts	posited	that	a	
microgravity-induced	cephalic	fluid	shift	elevate	intracranial	pressure	(ICP).	Feola	et	al.	[33]	
hypothesized	that	elevated	ICP	would	alter	the	peak	strain	environment	in	the	optic	nerve	head	
(ONH)	to	cause	tissue	remodeling	that	may	be	contributing	to	the	observed	ophthalmic	changes.	
They	also	suspected	that	variations	in	intraocular	pressure	(IOP)	and	mean	arterial	pressure	
(MAP)	would	affect	the	biomechanical	strain	in	the	OHN	tissues.	To	explore	that	explanation,	
they	implemented	a	finite	element	Analogous-mechanism	Model	in	which	a	simulated	structural	
mechanism	is	strongly	analogous	to	(functions	as	an	analog	of)	the	ocular	structure.		The	
geometry	of	the	analog	was	based	on	established	ocular	biomechanics	research,	and	included	
representing	coarse	grain	features	of	tissue	structures	known	to	play	significant	role	in	the	
observed	ophthalmic	changes:	sclera,	preliminary	neural	tissue,	lamina	cribrosa,	central	retinal	
vessel,	dura	mater	and	pia	mater	of	the	optic	nerve	sheath.	Furthermore,	an	annular	ring	was	
incorporated	around	the	scleral	canal	to	account	for	the	circumferential	alignment	of	the	scleral	
collagen	fibers	around	the	ONH.	The	open	source	package	Gmsh	(V2.8.3)	was	used	to	generate	
the	3D	finite	element	geometry	and	mesh,	and	open	source	FE	solver	FEBio	(V2.0)	was	used	to	
solve	for	all	simulations.	The	authors	used	Latin	hypercube	sampling	of	biologically	plausible	
regions	of	parameter	space	to	simulate	biomechanical	responses	of	their	analog	eye	structure	to	
various	combinations	of	simulated	ICPs,	as	well	as	varying	IOP,	MAP	and	simulated	tissue	
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mechanical	property	conditions.		Execution	results	showed	that	chronically	elevated	ICP	coupled	
with	interindividual	differences	in	simulated	optic	nerve	head	mechanical	properties	can	
influence	the	risk	for	experiencing	extreme	optic	nerve	strains.		The	authors	inferred	that	
individuals	with	both	soft	optic	nerve	or	pia	mater	and	elevated	ICP	would	be	especially	at	risk.	
•	 Example	V-3:		Rosiglitazone	is	a	PPARγ	agonist,	one	of	several	approved	insulin	sensitizers	used	
to	treat	diabetes.	Despite	being	on	the	market	for	over	a	decade,	the	drug	continues	to	be	
studied	in	the	lab	to	understand	the	mechanism	of	action	of	this	class	of	molecule.	In	Goto-
Kakizaki	rats,	which	are	a	rodent	model	of	early-developing,	non-obese	type-2	diabetes,	Gao	and	
Jusko	[31]	show	that	rosiglitazone	decreases	glucose	levels.	To	simulate	how	the	insulin/glucose	
regulation	might	work,	they	built	a	feedback	model—glucose	stimulating	insulin	production,	and	
insulin	increasing	glucose	consumption.	The	model	is	analogous	to	other	simple	feedback	
systems,	without	specifying	the	actual,	detailed,	biological	mechanism	(e.g.	intermediate	steps)	
for	glucose/insulin	co-regulation.		The	model	also	incorporates	two	pharmacodynamic	effects	of	
rosiglitazone	that	impact	this	feedback	system:	enhancing	insulin	sensitivity	(i.e.	increasing	the	
rate	of	insulin-dependent	loss	of	glucose)	and	inhibiting	glucose	production.	As	with	many	
models	of	pharmacology,	the	pharmacokinetic	part	uses	an	idealized	one-compartment	model	
to	fit	observed	drug	absorption	and	loss.	The	simulation	is	implemented	using	coupled	ODEs,	
plus	analytical	expressions	for	some	of	the	molecules.		Given	its	importance	to	diabetes	and	the	
system	under	study,	the	component	representing	the	time-dependent	body	weight	of	the	rats	
was	a	key	variable	being	simulated	along	with	the	molecular	components.		Guided	by	
experimental	measurements	(of	drug,	glucose,	and	insulin	levels	over	time),	the	model	was	
parameterized	for	control,	low	dose,	and	high	dose	rosiglitazone	cases.		The	match	between	
simulation	output	and	experiment	measurements	showed	that	the	Analogous-mechanism	
Model	explained	the	observations	sufficiently	well.		Using	that	model,	the	authors	identified	
drug	regimen	design	principles:	specifically,	to	enhance	insulin	sensitivity	in	the	long	term	(>	6	
weeks),	a	high-dose	drug	is	needed	continuously;	neither	lower-dose	nor	shorter-term	
treatment	succeeded	in	elevating	the	sensitivity.			
•	 Example	V-4:		Attempts	to	design	and	build	synthetic	cellular	memory	systems	using	
recombinases	have	thus	far	been	hindered	by	a	lack	of	validated	computational	models	of	a	
plausible	mechanism	representing	DNA	recombination.		The	predictive	capabilities	of	such	
models	are	needed	to	reduce	the	number	of	iterative	cycles	required	to	align	experimental	
results	with	design	performance	requirements.		Bowyer	et	al.	[32]	developed	and	validated	the	
first	Simulation	of	an	Analogous-mechanism	Model	for	how	DNA	recombination	might	occur.		
The	models	were	constructed	by	extracting	verified	biological	details	from	an	extensive	review	
of	the	experimental	literature	and	made	use	of	a	model	analogy	with	well-established	reactions	
networks	common	to	chemistry	and	chemical	engineering.		Three	essential	biological	details	for	
which	a	consensus	was	lacking	were	included/excluded	from	the	simulations.		The	
computational	model	consisted	of	a	system	of	ODEs,	each	representing	the	concentration	of	a	
distinct	biological	entity,	and	model	parameters	that	were	optimized	via	the	use	of	genetic	
algorithms	to	refine	parameter	values,	but	no	details	on	how	the	model	was	implemented	were	
provided.		Model	predictions	were	compared	to	experimental	data	to	determine	which	set	of	
details	might	represent	the	most	plausible	mechanisms	and	thus	serve	as	analogs	of	actual	
structural	details	by	which	DNA	recombination	works.		They	found	that	including	unidirectional	
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(versus	bidirectional)	excision,	limiting	recombinase	directionality	factor	to	monomeric	form	in	
solution	(versus	dimer	or	tetramer),	and	integrase	monomer	(versus	dimer)	binding	to	DNA	
produced	the	best	model	match	to	the	data.		Referring	to	Table	1,	the	contextual	location	this	
Analogous-mechanism	Model	is	implied	but	is	not	part	of	the	implemented	computational	
model.			
Group	C:	using	computation	to	support	and	enhance	model	mechanisms	
VI:	Simulation	of	a	Model	Mechanism	
The	computational	mechanisms	used	during	simulation	of	an	Analogous-mechanism	Model	have	
nothing	in	common	with	referent	mechanism’s	spatiotemporal	entities	and	activities	within	the	
biological	context.		When	a	description	of	a	Model	Mechanism	is	available	(III),	it	is	feasible	to	
change	that	reality	by	striving	to	actually	simulate	an	operating,	concretized	software	(virtual)	
version	of	the	Model	Mechanism.		The	research	goal	becomes	twofold.		1)	Create	a	discretized	
specification	of	the	operating	Model	Mechanism	to	guide	development	and	instantiation	of	a	virtual	
mechanism.		Doing	so	requires	meeting	this	requirement:	key	portions	of	the	virtual	Model	
Mechanism	actually	operate	during	execution	as	described	in	III	and	contribute	to	the	simulation	of	
Model	Mechanism	features.		2)	Output	and/or	measurements	taken	during	simulations	are	
qualitatively	and	quantitatively	similar	to	measurements	of	the	target	phenomenon.			
The	workflow	characterization	in	Figure	5A	is	similar	to	that	for	IV,	except	that	the	Model	
Mechanism	descriptions	(light	blue	box)	are	distinct	in	three	ways.		1)	Descriptions	of	entities	and	
activities	are	discretized	sufficiently	to	specify	in	software	a	virtual	analog	of	the	Model	Mechanism	
that	is	faithful	to	details	in	III	(e.g.,	see	[34,	35]).		2)	Evidence	is	presented	that	the	entities	and	
activities	of	the	virtual	analog	are	biomimetic.		3)	The	working	hypothesis	is	that	organized	operation	
of	software	entities	and	activities	will	be	capable	of	generating	a	biomimetic	phenomenon.		
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Figure	5:	Model	Mechanism:	from	simulation	to	instantiation	
Illustrated	are	snapshots	of	two	different	work	activities	built	upon	the	detailed	description	of	a	
Model	Mechanism	in	III.		Simulation	operation	is	not	illustrated.		A	requirement	for	both	is	that	
output	matches	target	phenomenon	measurements	within	some	tolerance.		(A)	Red	asterisks	
identify	characteristics	that	distinguish	a	Simulation	of	a	Model	Mechanism	from	V.		Agent-oriented	
simulation	methods	are	often	utilized.		To	the	extent	feasible,	envisioned	entity	activities	are	
described	using	probabilistic	and/or	deterministic	rules.		Often,	however,	to	simplify	technical	
implementation	challenges,	behaviors	of	all	or	some	Model	Mechanism	activities	during	execution	
are	simply	described	using	continuous	mathematics,	as	in	V,	using	physically	grounded	
parameterizations.		So	doing	prevents	some	or	all	of	the	software	mechanisms	during	execution	
from	meeting	the	definition	of	mechanism.		(B)	The	red	asterisk	identifies	a	characteristic	that	
distinguishes	this	implementation	from	VI.		Authors	strive	to	use	the	Model	Mechanism	
specifications	to	instantiate	a	software	analog	of	the	entire	Model	Mechanism.		The	product	is	a	
Virtual	Model	Mechanism.		To	build	credibility,	authors	demonstrate	that	a	parameterized	variant	of	
the	Virtual	Model	Mechanism	has	met	the	five	requirements	listed	in	the	text.		A	distinguishing	
element	is	that	features	of	the	software	mechanism	during	execution	are	observable,	measurable,	
and	hypothesized	to	have	analogous	biological	counterparts	(blue	arrow).			
To	achieve	computational	efficiencies	and/or	fine	grain	details,	such	as	receptor	trafficking,	
signaling	networks,	and	molecular	diffusion,	influences	of	some	entities	and	activities	within	the	
larger	Model	Mechanism	are	often	described	using	a	combination	of	rules	and	continuous	
mathematics,	as	in	V,	rather	than	being	implemented	as	discrete	biomimetic	entities	and	activities.		
Doing	so	causes	the	software	mechanisms	during	execution	to	fall	short	of	the	definition	of	
mechanism	[36].		Nevertheless,	an	accurate	descriptor	of	the	work	product	is	a	Simulation	of	a	
Model	Mechanism.		The	following	are	examples.		
•	Example	VI-1:	Simulations	of	Model	Mechanisms	are	being	used	to	help	design	and	improve	
therapeutic	interventions	in	disease	[37-39].		For	example,	they	are	providing	improved	insight	
into	possible	failure	modes	of	current	treatments	strategies	for	Tuberculosis	(TB).		Building	on	
their	multilevel,	multi-attribute	Model	Mechanism	of	an	immune	response	to	TB,	Linderman	et	
al.	[35]	explored	simulations	of	consequences	of	potential	new	pharmacological	interventions	on	
six	different	model	entities	and	activities,	including	simulating	immunomodulation	by	a	cytokine;	
the	consequences	of	oral	and	inhaled	antibiotics;	and	the	effect	of	vaccination.		Inline	with	the	
features	of	a	biological	mechanism	(Table	1),	their	Model	Mechanism	identifies	a	phenomenon,	
the	immune	response	of	TB	as	indicated	by	granuloma	formation	and	function.		Components	are	
represented	at	different	spatial	and	temporal	scales	describe,	starting	with	an	agent-based	
analogy	of	cell	behavior	(macrophages	and	T	cells)	across	a	cross-section	of	lung	tissue.		Through	
rule-based	probabilistic	interactions,	cell	behavior	is	simulated	in	response	to	a	bacterial	
environment.		At	the	lowest	levels	of	simulation	hierarchy,	ordinary	differential	equations	were	
solved	within	each	cell	agent	to	simulate	receptor/ligand	binding,	trafficking,	and	intracellular	
signaling.		Partial	differential	equations	were	solved	to	simulate	consequences	of	molecular	
diffusion.		By	linking	their	Simulation	of	a	Model	Mechanism	for	TB	to	ordinary	differential	
equation-based	pharmacokinetic	and	pharmacodynamic	models,	the	authors	simulated	
plausible	consequences	of	the	Model	Mechanism’s	behavior	during	exposure	to	antibiotics.		
While	simulations	rely	on	some	model	compartments	that	are	Analogous-mechanism	Models,	
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the	whole	system	is	arguably	a	Model	Mechanism.		It	is	biomimetic	and	represents	an	
interconnected	biological	mechanism	of	granuloma	formation	and	immune	response	that	
extends	from	molecular	to	organ	levels.			
•	Example	VI-2:	A	decade	ago,	several	laboratories	sought	improved	models	of	explanation	for	
vascular	patterning	defects	observed	in	diabetic	retinopathy	and	tumor	angiogenesis.	Evidence	
suggested	that	an	explanatory	mechanism	would	involve	disruption	of	1)	notch-driven	
specialization	of	endothelial	cells	into	leading	tip	cells	and	following	stalk	cells,	and	2)	a	feedback	
loop	that	links	VEGF-A	tip	cell	induction	with	delta-like	4	(Dll4)-notch-mediated	lateral	inhibition.	
Bentley	et	al.	[40]	constructed	a	hierarchical	Simulation	of	a	Model	Mechanism	to	explore	the	
phenomenon	of	angiogenesis	by	connecting	Analogous-mechanism	Models	of	these	processes	
into	a	large	biomimetic	system.		The	components	included	endothelial	cell	agents	and	
membrane	agents	with	multiple	cell	agents	arranged	as	a	cylindrical	capillary	with	each	cell	
having	membrane	agents	distributed	at	the	periphery.	The	study	explored	how	different	
simulated	VEGF	environments	and	filopodia	dynamics	would	affect	simulations	of	notch-
mediated	selection	of	tip	cells.	A	staged	simulation	(temporally	and	spatially)	first	relied	on	a	
rule-based	evaluation	of	membrane	processes	for	filopodium	retraction	or	extension	or	notch	
response	to	VEGF.	In	following,	the	spatial	sum	of	protein	levels	was	calculated	and	
redistributed	within	the	endothelial	cells	and	membrane	agents.	The	modeling	paradigm	closely	
follows	that	of	a	Model	Mechanism,	where	features	reflect	those	of	a	biological	mechanism	
(Table	1).	An	important	observation	of	the	simulations	was	that,	by	removing	information	that	
could	influence	simulated	cell	biasing,	the	simulated	Dll4-notch	lateral	inhibition	mechanism	
could	generate	an	alternating	pattern	of	cell	fates	characteristic	of	normal	tip	cell	selection.	The	
authors	inferred	from	simulation	results	that	abnormal	patterning	could	be	attributed	to	the	
dynamics	of	this	particular	sub-system,	rather	than	any	uncontrolled	bias.			
VII:	A	Virtual	Model	Mechanism	
This	characterization	differs	from	that	in	VI	in	one	important	way.		All	features	of	a	Model	
Mechanism	instantiated	in	software	meet	the	definition	of	mechanism	during	operation	and	may	
include	all	of	the	features	in	Table	1.		To	do	so,	five	requirements	are	specified	early	in	the	workflow	
to	guide	software	engineering,	mechanism	instantiation,	and	simulation	refinements.		1)	Evidence	is	
presented	that	entities	and	activities	of	the	virtual	mechanism	are	biomimetic.		2)	Features	of	the	
software	Model	Mechanism	during	execution	are	measurable.		3)	Biomimetic	phenomena	are	
generated	during	execution.		4)	Measurement	of	features	of	one	or	more	simulation	solutions	match	
or	mimic	measurements	of	the	target	phenomenon	within	some	tolerance	(e.g.,	see	[34,	41]).		5)	
Arguments	can	be	presented	that,	during	execution,	the	Model	Mechanism	will	have	a	biological	
counterpart	(blue	arrow	in	Figure	5B).	Here	are	three	examples.		
•	Example	VII-1:	Enhanced	mechanism-based	explanations	are	needed	to	anticipate,	prevent,	and	
reverse	the	liver	injury	caused	by	acetaminophen	and	other	drugs.		A	characteristic	
acetaminophen	phenomenon—the	target	phenomenon	for	this	example—is	that	hepatic	
necrosis	begins	adjacent	to	central	veins	in	hepatic	lobules	and	progresses	upstream.		The	
prevailing	(mechanism-oriented	spatiotemporal)	explanation	(PE)	is	that	location	dependent	
differences	in	reactive	metabolite	formation	within	hepatic	lobules	(called	zonation)	are	
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necessary	and	sufficient	requisites	to	account	for	the	phenomenon.		Progress	has	been	stymied	
because	challenging	that	hypothesis	in	mice	would	require	sequential	intracellular	
measurements	at	different	lobular	locations	within	the	same	mouse,	which	is	infeasible.		Smith	
et	al.	[34]	circumvent	that	impediment	by	performing	experiments	on	virtual	Mouse	Analogs,	
where	each	is	equipped	with	an	in	silico	liver	that	achieved	multiple	validation	targets.		
Components	and	spaces	at	all	levels	of	granularity	are	written	in	Java,	utilizing	the	MASON	multi-
agent	simulation	toolkit.		An	accurate	causal	model	of	the	PE	that	exhibits	all	Table	1	features	
was	instantiated	and	parameterized	so	that,	upon	dosing	with	objects	representing	
acetaminophen,	metabolism	and	pharmacokinetic	validation	targets	were	achieved.		However,	
the	authors	demonstrated	that	the	PE	failed	to	achieve	the	target	phenomenon.		Two	
parsimoniously	more	complex	variants	also	failed	to	achieve	the	target	phenomenon,	but	a	
fourth	variant	met	stringent	tests	of	sufficiency.		Execution	of	that	forth	Computational	Model	
Mechanism	provided	a	multilevel	biomimetic	causal	explanation	of	key	temporal	features	of	
acetaminophen	hepatotoxicity	in	mice	including	the	target	phenomenon.		The	authors	argue	
that	the	causal	explanation	provided	during	execution	is	strongly	analogous	to	the	actual	causal	
mechanism	in	mice.			
•	Example	VII-	2:	Inflammation	is	not	the	result	of	one	cell	or	molecule	acting	alone.		It	is	a	
multicellular	process	that	can	be	highly	localized	and	yet	also	have	diffuse	actions.	One	of	the	
keys	to	understanding	tissue-level	morphogenesis	and	spatially	localized	or	heterogeneous	
processes	such	as	inflammation	is	to	explicitly	study	the	spatial	component	-	how	the	cells	are	
arranged	in	the	tissue	and	the	influences	that	they	have	on	each	other.	Thus,	to	gain	insight	into	
the	pathogenesis	of	gastrointestinal	inflammatory	diseases,	Cockrell	et	al.	[42]	developed	a	
multi-level,	discrete-event	Model	Mechanism	that	is	used	to	study	scenarios	of	how	simulated	
cellular	and	molecular	pathways	may	govern	morphogenesis	and	inflammation	in	healthy	and	
disease	ileal	mucosal	dynamics.	The	system	includes	individual	agents	representing	five	different	
cell	types,	each	with	multiple	independently	acting	instantiations	at	different	physical	locations.		
Cell	agents	have	specific	behaviors	(proliferation,	death,	anoikis,	etc.)	and	can	influence	each	
other's	decision-making	process.		Inside	each	agent,	there	is	also	a	simulated	signaling	network.		
The	system	uses	algebraic	rules	to	simulate	most	of	the	different	components,	including	a	
representation	of	extracellular	paracrine	signaling	between	cells	(with	the	addition	of	a	grid-
based	partial	differential	equation	to	simulate	consequences	of	diffusion),	the	dynamics	of	the	
simulated	intracellular	signaling	networks,	and	(using	the	current	values	of	key	intracellular	
signaling	components	as	a	basis)	the	likelihood	of	cell	agents	exhibiting	each	possible	behavior.		
By	simulating	cell	behavior	in	a	virtual	world	that	is	analogous	to	biological	microenvironments,	
the	system	can	generate	measurable	phenomena	(predictions)	at	multiple	levels.		Simulations	
provide	insight	into	plausible	pathological	processes,	including	crosstalk	between	
morphogenesis	and	inflammation,	and	the	effects	of	cell	death	on	tissue	health.		
•	Example	VII-3:	Changes	to	savanna	ecosystems	related	to	climate	change	and	land	use	practices	
are	linked	to	fluctuations	in	savanna	bird	community	structures,	functional	traits,	and	risk	of	
extinction.		Better,	more	insightful	models	of	explanation	are	needed	to	support	policy	changes.		
However,	detailed	species-specific	data	for	a	given	ecosystem	are	often	limited.	As	a	method	
test	case	for	overcoming	such	limitations,	Scherer	et	al.	[43]	used	an	agent-oriented	approach	
(implemented	in	NetLogo)	that	merged	trait-based	and	individual-based	simulation	methods	to	
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predict	how	different	bird	functional	types	might	change	in	response	to	concurrent	alterations	
to	savanna	rangeland	from	a	combination	of	climate	change	and	land	use.		The	entire	simulated	
ecosystem	operates	during	execution	as	a	Model	Mechanism.		Contained	within	are	all	of	the	
features	listed	in	Table	1.		The	system	includes	a	spatial	and	stochastically	varying	set	of	entities	
representative	of	the	type	of	individual,	home	range,	vegetation,	landscape,	and	environment.		
Each	entity	was	characterized	by	a	set	of	state	variables,	examples	of	which	include	age	and	
reproductive	status,	or	grasses,	shrubs,	or	trees.		Executions	advance	in	uniform	steps	that	map	
to	an	interval	of	up	to	100	years,	and	progress	by	randomly	selecting,	calculating,	and	updating	
properties	that	control	the	spatial	composition	and	configuration	of	simulated	habitat	and	
animals.		Simulation	results	provided	possible	explanations	for	why	simulated	extinction	risks	for	
simulated	larger-	bodied	insectivores,	omnivores,	and	small-bodied	species	were	impacted	
differently	by	changes	in	simulated	shrub-grass	ratio	and	clumping	intensity	of	shrub	patches.	
Such	predictions	could	prove	essential	for	identifying	better	policies	for	conservation	
management.			
RELEVANT	INFORMATION,	MULTIPLE	SOURCES	
Essential	relevant	information	from	a	variety	of	sources	is	needed	to	establish	and	enhance	the	
credibility	of	improved	insights	that	may	be	derived	from	IV–VII.		The	Figure	2B	and	2C	spectra	
characterize	two	important	sources.		The	three	Figure	6	spectra	identify	additional	information	
sources	and	types.		The	Figure	6	spectra	are	more	closely	linked	to	methodology	than	are	the	
workflow	characterizations	in	Figures	3-5.		Having	essential	information	available	enables	authors	
and	readers	to	identify	approximate	locations	on	all	five	spectra,	which	improves	clarity	and	brings	
into	focus	the	characteristics	that	distinguish	among	IV–VII.		
	
Figure	6:	Characteristics	three	sources	and	types	of	relevant	information		
These	three	spectra	are	distinct	from	those	in	Figure	2.		They	bring	into	focus	characteristics	of	
methods	and	approach	used	in	workflows	that	distinguish	among	IV–VII.		(A)	The	relationship	
between	I,	II,	or	III	and	the	corresponding	mathematical	description	must	be	clear.		(B)	Expanding	a	
model	or	combining	it	with	other	models	[44,	45]	(e.g.,	to	create	a	hybrid	model)	is	a	strategy	used	
to	improve	explanatory	descriptions.		The	choice	of	mathematical	description	used	for	the	expansion	
or	combination	can	influence	faithfulness	of	deductive	transformations.		Four	examples	of	
commonly	used	mathematical	model	types	are	shown	to	illustrate	that	different	types	occupy	
different	relative	locations.		Some	mathematical	model	types	cannot	be	easily	modified	and	remain	
faithful	to	the	target	phenomenon	while	also	preserving	the	original	meaning(s)	of	the	model’s	
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terms	and	model-to-target	mappings	provided	in	the	explanatory	descriptions.		(C)	This	spectrum	
illustrates	that	implementation	decisions	(primarily	within	the	yellow	boxes	in	Figures	4	and	5)	
influence	the	fidelity	of	the	biomimesis	that	can	be	built	into	the	simulations	during	execution.		
Stronger	analogies	between	the	biology	and	model	mechanisms	during	execution	are	expected	to	
improve	clarity,	credibility	and	scientific	usefulness.			
Spectrum	6A	characterizes	the	mathematical	descriptions	used	in	IV–VI.		Information	is	lost	
during	derivation	from	the	primarily	prosaic	description	(including	induction	from	data)	in	II	and	III	
to	mathematical	descriptions.		Clarity	about	what	is	and	is	not	lost	can	influence	credibility.		For	
example,	the	assumption	behind	Simulation	of	an	Analogous-mechanism	Model	is	that,	if	the	model	
were	made	real,	then	some	version	of	the	phenomenon	generated	during	operation	would	mimic	
the	referent	phenomenon.		In	most	reports,	the	focus	is	primarily	on	mimicking	the	referent	
phenomenon,	and	much	less	so	on	the	model’s	entities,	activities,	and	their	organization	during	
phenomenon	generation.		Consequently,	it	is	often	the	case	that	mathematical	descriptions	are	
imbalanced,	which	can	limit	clarity	and	credibility.			
Spectrum	6B	is	about	(primarily	deductive)	transformations	of	the	descriptions	in	I–III.		The	
research	goal	of	improving	mechanism-oriented	explanations	often	involves	inferring	plausible	
biological	details	from	explorations	of	the	model’s	behavior	and	then	seeking	transformations	(ways	
to	change	computational	features)	that	provide	improvement.		Formal	Methods	refer	to	the	
computer	science	(and	mathematics)	that	allows	such	transformations	to	be	rigorous	enough	to	
reason	over,	i.e.,	to	make	them	purely	deductive.		Particular	types	of	mathematical	models	(e.g.,	
ODEs)	cannot	be	easily	modified	without	breaking	the	extent	to	which	the	model	represents	the	
description	in	II	or	III	and	maps	to	the	target	phenomenon.		Faithful	deduction	over	a	simulation,	
including	modifications	that	are	faithful	to	the	target	phenomenon,	are	those	that	preserve	the	
original	meaning(s)	of	the	model’s	terms	and	model-to-target	phenomenon	mappings	(for	example	
[44]).		The	expectation	is	that	credibility	of	IV–VII	will	increase	as	faithfulness	to	deductive	
transformations	from	mathematical	descriptions	increases.	
Spectrum	6C	illustrates	that	implementation	decisions	influence	the	fidelity	of	biomimesis	
built	into	a	simulation	during	execution.		We	anticipate	that	the	deeper	the	insight,	the	stronger	the	
analogy	between	the	biology’s	mechanisms	and	simulation’s	mechanisms.		Thus,	credibility	will	
increase	by	increasing	structural	analogies	between	implementations	simulating	the	target	
phenomenon	and	the	biological	system	generating	the	target	phenomenon.		
Moving	rightward	on	spectra	2B	and	2C	involves	incorporating	deeper	(validated)	insight	into	
an	expanding	variety	of	interconnected	biological	processes	and	phenomena.		Mechanism-oriented	
models	that	are	developing	that	insight	into	an	expanding	variety	of	phenomena	will	be	moving	
rightward	on	the	Figure	6	spectra.		As	a	consequence,	implementations	must	change	during	each	
move	to	the	right.		During	those	changes,	information	that	can	influence—bias—simulation	output	
can	be	lost	and/or	added.		Documenting	those	influences	enhances	credibility.		The	absence	of	such	
documentation	risks	creating	a	barrier	to	credibility,	thus	limiting	scientific	usefulness.			
Preprint:	Jan.	05,	2018	
	
23	
23	
WORKFLOW,	PROVENANCE,	AND	HYBRID	MODELS	
Most	biological	scientists	and	clinicians	have	a	general	appreciation	for,	and	understanding	of,	the	
workflow,	the	systems	utilized,	and	methods	employed	in	wet-lab	research.		When	they	read	a	
research	article	reporting	results	of	experiments,	that	knowledge	influences	their	assessment	of	
credibility.		Biological	scientists	and	clinicians	outside	of	the	simulation	field	may	be	drawn	to	(and	
may	consider	reading)	a	simulation-focused	research	report	due	to	the	prospect	for	improved	
explanatory	insight	or	practical	utility.		However,	they	do	not	have	a	corresponding	appreciation	for,	
or	understanding	of,	the	workflow,	the	systems	utilized,	or	the	methods	employed.		Thus,	there	is	a	
significant	risk	that	missing	information	and	lack	of	clarity	will	erode	the	reader’s	assessment	of	the	
credibility	of	arguments	presented,	and	of	simulation	approaches	in	general.	
The	credibility	of	inferences	about	a	phenomenon	based	on	results	of	wet-lab	experiments	
depends	on	having	easy	access	to	the	experiment’s	provenance	[46],	i.e.,	full	context	of	the	
experiment	along	with	adequate	descriptions	of	methods,	materials,	and	other	important	workflow	
details.		Removing	or	distancing	observations	and/or	data	from	the	experiment’s	provenance	
abstracts	away	both	information	and	knowledge,	thus	weakening	justifications	for	their	application	
or	use	elsewhere.	By	analogy,	the	credibility	of	explanations	provided	by	simulations	for	how	a	
phenomenon	may	be	generated	depends	on	use	context,	and	includes	having	easy	access	to	the	
provenance	of	IV–VII	[47].		Provenance	begins	with	I–III	and	includes	the	full	context	of	the	
simulation	activities.		Also	by	analogy,	unlinking	an	element	(e.g.,	a	mathematical	description	or	
software	implementation	detail)	from	the	information	and	knowledge	provided	by	the	original	use	
context	and	provenance	for	application	or	reuse	elsewhere	can	weaken	or	eliminate	justifications	for	
the	intended	application	or	reuse,	thus	eroding	credibility	and	limiting	scientific	usefulness.		
It	is	now	common	to	encounter	biology	simulation	research	reports	that	seek	merged	
explanations	of	two	or	more	phenomena	or	a	description	of	phenomena	across	multiple	biological	
levels	or	scales.		The	software	instantiations,	commonly	referred	to	as	hybrid	models,	require	means	
for	the	different,	originally	separate	and	independent	mechanism-oriented	models	to	interact	during	
execution.		Those	means	include	adding	software	features	and	making	changes	to	the	previously	
independent	implementations.		Describing	the	product	of	that	process	as	a	hybrid	alerts	readers	to	
expect	the	merged	system	to	behave	in	new	ways.		Some	behaviors	will	be	intended,	but	others	may	
be	unintended.		The	situation	is	somewhat	analogous	to	combining	two	reagents	during	a	wet-lab	
protocol	when,	under	some	conditions,	doing	so	risks	an	adverse	interaction.		The	importance	of	
providing	clear	details	is	obvious.		
CONCLUDING	REMARKS	
Although	credibility	and	clarity	are	often	correlated,	other	factors	can	have	even	greater	influence	
on	explanatory	credibility.		Each	element	in	the	I–VII	characterizations	will	“resonate”	differently	
with	different	scientists,	clinicians,	and	stakeholders.		Here	are	three	examples:	1)	The	evidence	
selected	to	support	a	description	of	an	Analogous-mechanism	Model	(II)	may	resonate	well	with	
engineers	and	system	biologists	but	less	so	with	oncologists.		2)	For	a	particular	characterization,	the	
interpretations	offered	by	authors	in	the	context	of	selected	simulation	results	will	likely	resonate	
differently	with	scientists	approaching	the	problem	from	basic	science	and	clinical	perspectives.		3)	
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The	extent	to	which	a	particular	set	of	mathematical	expressions	or	software	engineering	methods	
resonates	with	a	simulation	researcher	will	likely	have	a	significant	impact	on	that	person’s	
determination	of	whether	a	particular	computational	mechanism-oriented	model	is	sufficiently	
mechanistic	or	not,	which,	in	turn,	may	impact	that	person’s	assessment	of	credibility.		There	are,	of	
course,	other	influences	and	even	larger	issues	to	consider.		For	example,	the	interpretation	of	what	
is	happening	within	all	the	above	workflows	is	part	of	the	philosophy	of	science.		We	put	these	
important	influences	aside	for	now;	they	are	beyond	the	scope	of	this	overview.		
Increasing	complexity	in	pursuit	of	mechanism-oriented	models	that	improve	explanatory	
credibility	is	an	explicit	strategy	within	biology	simulation	research	(e.g.,	see	[27,	45,	47]).		For	the	
larger	community	of	biologists,	a	priority	is	achieving	deeper,	more	useful	explanations	of	
phenomena	that	facilitate	advancing	both	science	and	health.		The	scientific	usefulness	of	biology	
simulation	as	a	discipline	will	become	more	evident	to	the	larger	community	as	credible	multi-
phenomena	explanations	become	available.		Achieving	credible	multi-phenomena	explanations	
requires	moving	rightward	on	all	spectra	in	Figures	2	and	6,	but	doing	so	requires	increasing	support	
from	the	larger	biology	community.		Improving	clarity,	semantics	and	otherwise,	is	a	necessary	and	
essential	small	step	to	achieving	that	increased	support.		
By	characterizing	I–III	and	IV–VII	we	demonstrate	how	semantic	clarity	can	be	improved	even	
as	the	complexity	of	those	models	of	explanation	increases.		These	categories	of	types	of	models	and	
simulations	may	serve	as	a	foundation	for	a	clear	ontology	of	mechanism-based	simulation	research	
in	biology.				
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